The Marked Chart Wire · Business
Vertex Pharmaceuticals
Vertex Pharmaceuticals reports third-quarter revenue of $3.43 billion
Vertex Pharmaceuticals reported third-quarter revenue of $3.43 billion, matching expectations. Earnings per share came in at $4.76, slightly below the expected $4.78.
